These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33320900)

  • 1. Socio-economic condition and lack of virological suppression among adults and adolescents receiving antiretroviral therapy in Ethiopia.
    Plymoth M; Sanders EJ; Van Der Elst EM; Medstrand P; Tesfaye F; Winqvist N; Balcha T; Björkman P
    PLoS One; 2020; 15(12):e0244066. PubMed ID: 33320900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.
    Siefried KJ; Mao L; Kerr S; Cysique LA; Gates TM; McAllister J; Maynard A; de Wit J; Carr A;
    PLoS One; 2017; 12(4):e0174613. PubMed ID: 28369066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with recent unsuppressed viral load in HIV-1-infected patients in care on first-line antiretroviral therapy in South Africa.
    Joseph Davey D; Abrahams Z; Feinberg M; Prins M; Serrao C; Medeossi B; Darkoh E
    Int J STD AIDS; 2018 May; 29(6):603-610. PubMed ID: 29334886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy.
    Melku M; Abebe G; Teketel A; Asrie F; Yalew A; Biadgo B; Kassa E; Damtie D; Anlay DZ
    Environ Health Prev Med; 2020 Aug; 25(1):43. PubMed ID: 32838734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with immunological and virological discordant responses to highly active antiretroviral therapy among adult HIV positive individuals in Ethiopia: A cross-sectional study.
    Manaye GA; Abateneh DD; Asmare WN; Abebe M
    Medicine (Baltimore); 2021 Nov; 100(47):e27624. PubMed ID: 34964727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study.
    Afrane AKA; Goka BQ; Renner L; Yawson AE; Alhassan Y; Owiafe SN; Agyeman S; Sagoe KWC; Kwara A
    BMC Infect Dis; 2021 Aug; 21(1):731. PubMed ID: 34340689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with viral non-suppression among adolescents living with HIV in Cambodia: a cross-sectional study.
    Chhim K; Mburu G; Tuot S; Sopha R; Khol V; Chhoun P; Yi S
    AIDS Res Ther; 2018 Nov; 15(1):20. PubMed ID: 30445984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study.
    Desta AA; Woldearegay TW; Futwi N; Gebrehiwot GT; Gebru GG; Berhe AA; Godefay H
    BMC Infect Dis; 2020 Jan; 20(1):4. PubMed ID: 31898535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral suppression among children and their caregivers living with HIV in western Kenya.
    Humphrey JM; Genberg BL; Keter A; Musick B; Apondi E; Gardner A; Hogan JW; Wools-Kaloustian K
    J Int AIDS Soc; 2019 Apr; 22(4):e25272. PubMed ID: 30983148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018.
    Mhlanga TT; Jacobs BKM; Decroo T; Govere E; Bara H; Chonzi P; Sithole N; Apollo T; Van Damme W; Rusakaniko S; Lynen L; Makurumidze R
    AIDS Res Ther; 2022 Jul; 19(1):34. PubMed ID: 35810317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia.
    Fiseha T; Alemu W; Dereje H; Tamir Z; Gebreweld A
    PLoS One; 2021; 16(4):e0250328. PubMed ID: 33905435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attrition Rates in HIV Viral Load Monitoring and Factors Associated With Overdue Testing Among Children Within South Africa's Antiretroviral Treatment Program: Retrospective Descriptive Analysis.
    Haeri Mazanderani A; Radebe L; Sherman GG
    JMIR Public Health Surveill; 2024 May; 10():e40796. PubMed ID: 38743934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief Report: Interferon-γ-Inducible Protein 10-A Potential Marker for Targeted Viral Load Monitoring of Antiretroviral Treatment?
    Reepalu A; Arimide DA; Balcha TT; Björkman P; Medstrand P
    J Acquir Immune Defic Syndr; 2020 Apr; 83(5):475-478. PubMed ID: 31917753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland.
    Jobanputra K; Parker LA; Azih C; Okello V; Maphalala G; Kershberger B; Khogali M; Lujan J; Antierens A; Teck R; Ellman T; Kosgei R; Reid T
    PLoS One; 2015; 10(2):e0116144. PubMed ID: 25695494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda.
    Nakalega R; Mukiza N; Kiwanuka G; Makanga-Kakumba R; Menge R; Kataike H; Maena J; Akello C; Atuhaire P; Matovu-Kiweewa F; Ndikuno-Kuteesa C; Debem H; Mujugira A
    BMC Infect Dis; 2020 Oct; 20(1):727. PubMed ID: 33023498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013.
    Nash D; Tymejczyk O; Gadisa T; Kulkarni SG; Hoffman S; Yigzaw M; Elul B; Remien RH; Lahuerta M; Daba S; El Sadr W; Melaku Z
    J Int AIDS Soc; 2016; 19(1):20637. PubMed ID: 27113335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of virological failure among HIV clients on second-line antiretroviral treatment at Felege-hiwot and University of Gondar comprehensive specialized hospitals in the Amhara Region, Northwest Ethiopia: A case-control study.
    Ayenew G; Agumas Y; Shibabaw T; Getaneh G; Getie M
    PLoS One; 2024; 19(7):e0289450. PubMed ID: 38980874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of viral load non-suppression among adolescents in Mbale District, Eastern Rural Uganda.
    Maena J; Banke-Thomas A; Mukiza N; Kuteesa CN; Kakumba RM; Kataike H; Kizito S; Babirye JA; Nakalega R
    AIDS Res Ther; 2021 Dec; 18(1):91. PubMed ID: 34863196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early post-partum viremia predicts long-term non-suppression of viral load in HIV-positive women on ART in Malawi: Implications for the elimination of infant transmission.
    Landes M; van Lettow M; van Oosterhout JJ; Schouten E; Auld A; Kalua T; Jahn A; Tippett Barr BA
    PLoS One; 2021; 16(3):e0248559. PubMed ID: 33711066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.